Table 53Adverse events of sitagliptin compared with placebo (continued)a

Mohan, 200945Hanefeld, 200746
Adverse eventS100PBOS25S50S100S50BIDPBO
Hypoglycemia000.90.91.80.90
Nausea--------------
Vomiting--------------
Diarrhea--------------
Gastritis--------------
Abdominal pain--------------
Gastrointestinal (overall)5.10.611.89.19.18.113.5
Nasopharyngitis----6.3–9.11.8------
Upper respiratory tract infection2.82.8--------
Influenza--------------
Headaches--------------
Urinary tract infections--------------

Abbreviations: BID, twice daily; PBO, placebo; S100, sitagliptin 100 mg daily.

a

Data are presented as percentages.

From: Results

Cover of Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations
Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report [Internet].
Jonas D, Van Scoyoc E, Gerrald K, et al.
Portland (OR): Oregon Health & Science University; 2011 Feb.
Copyright © 2011, Oregon Health & Science University.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.